X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Bharat Biotech's intranasal vaccine, BBV154, received regulatory approval for second phase trials in August. The trials will begin in a couple of weeks after permission is granted by the committee.
Lead Product(s): Chad SARS-COV-2
Therapeutic Area: Infections and Infectious Diseases Product Name: BBV154
Highest Development Status: Phase IProduct Type: Vaccine
Recipient: Bharat Biotech
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable September 09, 2021
Details:
After ten days of treatment with Phytorelief along with standard management, 83% of Covid-19 patients, with mild or moderate symptoms, turned negative in a trial conduct in AIIMS Patna.
Lead Product(s): Curcuminoid,Ellagic acid,Gingerol
Therapeutic Area: Infections and Infectious Diseases Product Name: Phytorelief-CC
Highest Development Status: UndisclosedProduct Type: Small molecule
Recipient: Alchem International Private Ltd
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable June 10, 2021
Details:
In the Animal experimental study, doctors have found that the pace of diabetes growth can be halted if allopathic drug is integrated with BGR-34, a herbal formulation enriched with antioxidant properties which stops bad cholesterol from accumulating in the heart arteries.
Lead Product(s): BGR-34,Glibenclamide
Therapeutic Area: Endocrinology Product Name: BGR-34
Highest Development Status: ApprovedProduct Type: Undisclosed
Partner/Sponsor/Collaborator: CSIR
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable February 03, 2021
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
